Simulations to Assess Phase II Noninferiority Trials of Different Doses of Capecitabine in Combination With Docetaxel for Metastatic Breast Cancer

Tekijä Bruno, R, Lindbom, L, Schaedeli Stark, F, Chanu, P, Gilberg, F, Frey, N, Claret, L
Julkaistu 2012

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

Tekijä Cassidy, J, Clarke, S, Díaz-Rubio, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Rittweger, K, Gilberg, F, Saltz, L
Julkaistu 2011